Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
5
VanEck Oil Services ETF
OIH
US Stock MarketDetailed Quotes
Altamira Therapeutics Ltd (CYTOF)
- 0.0711
- 0.00000.00%
15min DelayTrading Jun 10 15:46 ET
406.37KMarket Cap-0.06P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.0711Prev Close0.00Turnover0.00%Turnover RatioLossP/E (Static)5.72MShares0.147952wk High0.10P/B404.95KFloat Cap0.050152wk Low--Dividend TTM5.70MShs Float1592.0000Historical High--Div Yield TTM0.00%Range %0.0501Historical Low--Avg Price1Lot Size
Altamira Therapeutics Ltd (CYTOF) News
Altamira Therapeutics GAAP EPS of -$0.55
Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules
Altamira Therapeutics to Host First Half 2025 Financial Results and Business Update Call on August 29, 2025
Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Intranasal Betahistine
Earnings Call Summary | Altamira Therapeutics Ltd(CYTOF.US) Q4 2024 Earnings Conference
Altamira Therapeutics Ltd | 20-F: FY2024 Annual Report
Altamira Therapeutics GAAP EPS of -$2.99
Express News | Altamira Therapeutics Ltd - Plans Partial Spin-off of Rna Delivery Business
Altamira Therapeutics Ltd | 6-K: Report of foreign private issuer (related to financial reporting)
Express News | Altamira Therapeutics Announces Collaboration on Radiopharmaceutical Targeting Strategies
Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA
Altamira Therapeutics Announces Transition From NASDAQ to OTC Markets
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Altamira Therapeutics Receives Letter From Nasdaq Qualifications Department That It Is No Longer In Compliance
Express News | Altamira Therapeutics: Got on Sept 30, a Letter From Nasdaq That It No Longer Complied With Rule 5550(a)(2) of Nasdaq's Listing Rules
Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray
Earnings Call: Altamira Therapeutics Focuses on RNA Delivery Growth
Altamira Therapeutics Ltd. (CYTO) Q2 2024 Earnings Call Transcript Summary
Altamira Therapeutics Reports Narrowed Losses
Altamira Therapeutics H1 2024 EPS $(2.11) Up From $(21.55) YoY
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
A critical window for U.S.-Iran talks has opened! According to Bloomberg, the U.S. and Iran are 'close' to signing an agreement around the u
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm